Wordt geladen...
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
BACKGROUND: To analyze the effects of BRCA1/2 mutations on chemotherapy response scores (CRS) and survival in a cohort of patients with advanced-stage ovarian cancer who were treated with neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS). METHODS: We retrospectively reviewe...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057666/ https://ncbi.nlm.nih.gov/pubmed/32131779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6688-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|